-
RIL buys majority stake in Netmeds
expresspharma
August 19, 2020
The Rs 620 crore deal gives RIL 60 per cent holding in equity capital of Vitalic and 100 per cent direct equity ownership of its subsidiaries — Tresara Health, Netmeds Market Place and Dadha Pharma Distribution.
-
SeQuent Scientific to sell stake in Strides Pharma
expresspharma
August 14, 2020
Arun Kumar’s Family Office, part of the existing promoters of SeQuent Scientific to purchase 3.31 million shares for Rs 1,573 million.
-
Sharp Acquires 25% Stake in Berkshire Sterile Manufacturing
contractpharma
August 10, 2020
Agreement will allow Sharp’s Clinical division, via BSM, to offer sterile fill/finish services.
-
Private Equity Stake Rising Among Dermatology Practices
drugs
July 25, 2019
Private equity (PE) firms have a stake in an increasing number of dermatology practices throughout the United States.
-
Permira Funds to Acquire Majority Stake in Quotient
contractpharma
July 19, 2019
Investment will support Quotient’s growth plans to expand formulation development and manufacturing capabilities.
-
Everstone to sell controlling stake in Rubicon Research
biospectrumasia
April 08, 2019
Everstone’s Singapore fund had acquired a controlling stake in Rubicon and along with co-investor Mankekars, bought out Kotak Private Equity and other shareholders and also invested primary capital in the company
-
AstraZeneca to buy 9.8% stake in France’s Innate Pharma
expressbpd
October 24, 2018
AstraZeneca will buy the stake via around 6.26 million new shares
-
Strides Pharma’s promoter sells stake worth ₹20 cr
financialexpress
September 10, 2018
According to the block deal data available with the NSE, Abusha offloaded 4 lakh shares, amounting to 0.45 per cent stake in the firm
-
Israel's Together Pharma to buy 50 percent stake of German cannabis
biospectrumasia
September 03, 2018
Together Pharma, which produces medical cannabis had signed a deal to buy a controlling 50.01 percent stake in an unnamed German company, which is one of its customers, for 2 million euros.
-
Bayer to acquire stake in Monsanto India
financialexpress
June 14, 2018
Bayer group has launched the process for over ₹ 1,300 crore open offer to acquire up to 26 per cent additional stake in Monsanto India, following global acquisition of the US biotech major for $ 63 billion.